Main Topic Area
All Topic Areas
1 - 10 of 682 more >>
Articles
1 - 5 of 266 more >>
- Vulvar Cancer Treatment
Treatment may be one of the following: Wide local excision or laser surgery or a combination of both. Skinning vulvectomy. Ointment containing a chemotherapy drug. Treatment may be one of the following: Wide local excision. Radical local excision plus taking out all nearby lymph nodes in the groin and upper part of the thigh on the same side as the cancer. Radical vulvectomy and removal of the lymph nodes in the groin on one or both sides of the body. Radiation therapy alone (in selected...
National Cancer Institute
- Vaginal Cancer Treatment
Treatment may be one of the following: Surgery to remove all or part of the vagina (vaginectomy). This may be followed by skin grafting to repair damage done to the vagina. Internal radiation therapy.Laser surgery.Intravaginal chemotherapy. Treatment of stage I cancer of the vagina depends on whether a patient has squamous cell cancer or adenocarcinoma. If squamous cancer is found, treatment may be one of the following: Internal radiation therapy with or without external beam radiation therapy....
National Cancer Institute
- Thyroid Cancer Treatment
Treatment may be one of the following: Surgery to remove the thyroid (total thyroidectomy). This may be followed by hormone therapy and radioactive iodine.Surgery to remove one lobe of the thyroid (lobectomy), followed by hormone therapy. Radioactive iodine also may be given following surgery. Treatment may be one of the following: Surgery to remove the entire thyroid (total thyroidectomy) and lymph nodes where cancer has spread. Total thyroidectomy followed by radiation therapy with...
National Cancer Institute
- The NCI Cancer Centers Program
The National Cancer Institute (NCI) Cancer Centers Program comprises more than 50 NCI-designated cancer centers engaged in multidisciplinary research to reduce cancer incidence, morbidity, and mortality. Through Cancer Center Support grants, this program supports three types of centers: Comprehensive Cancer Centers conduct programs in all three areas of research—basic research, clinical research, and prevention and control research—as well as programs in community outreach and...
- Testicular Cancer Treatment
Recurrent testicular cancer is cancer that has recurred (come back) after it has been treated. The cancer may come back many years after the initial cancer, in the other testicle, or in other parts of the body. Treatment of recurrent testicular cancer may include the following: Combination chemotherapy. High-dose chemotherapy with bone marrow transplantation. Surgery to remove cancer that has either:come back more than 2 years after complete remission; or come back in only one place and does...
National Cancer Institute
Organizations
1 - 5 of 72 more >>
- Sickle Cell Information Center, The - http://www.scinfo.org/
- Sickle Cell Disease Association of America, Inc. - http://www.sicklecelldisease.org
- American Sickle Cell Anemia Association - http://www.ascaa.org/
- Sickle Cell Disease Association of America -
- Georgia Comprehensive Sickle Cell Center at Grady Health System -
News
1 - 5 of 11591 more >>
- Type 1 diabetes linked to pancreatic cancer risk
Reuters - Thu, 01 Mar 2007 05:24 EST
- First Evidence Of Stem Cells In Pancreatic Tumors
ScienceDaily - Mon, 12 Feb 2007 04:00 EST
- Genes Discovered That Can Slow Cell Division And May Fight Cancer
MedicalNewsToday - Sat, 03 Mar 2007 12:00 EST
- Threshold Pharmaceuticals Announces That A Phase 3 Clinical Trial Of Glufosfamide For Treatment Of Pancreatic Cancer Did Not Meet Its Primary Endpoint
MedicalNewsToday - Tue, 27 Feb 2007 08:00 EST
- UIC Named NIH Islet Cell Resource Center
MedicalNewsToday - Sun, 31 Dec 2006 06:00 EST
Clinical Trials
1 - 5 of 11240 more >>
- A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors.
ClinicalTrials.gov Identifier: NCT00428597 - Recruiting
Carcinoma, Islet Cell
- Pancreatic Islet Cell Transplantation - A Novel Approach to Immunosuppression
ClinicalTrials.gov Identifier: NCT00530686 - Recruiting
Islet Cell Transplantation; Type 1 Diabetes
- Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00058201 - Recruiting
acinar cell adenocarcinoma of the pancreas; duct cell adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer; ...
- Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00112528 - Active, not recruiting
duct cell adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
- R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00005832 - Active, not recruiting
childhood gastrointestinal cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; ...

Not Signed In -

